Cargando…

Use of 9-Valent Human Papillomavirus (HPV) Vaccine: Updated HPV Vaccination Recommendations of the Advisory Committee on Immunization Practices

Detalles Bibliográficos
Autores principales:	Petrosky, Emiko, Bocchini, Joseph A., Hariri, Susan, Chesson, Harrell, Curtis, C. Robinette, Saraiya, Mona, Unger, Elizabeth R., Markowitz, Lauri E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	U.S. Centers for Disease Control 2015
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4584883/ https://www.ncbi.nlm.nih.gov/pubmed/25811679

Ejemplares similares

Human Papillomavirus Vaccination for Adults: Updated Recommendations of the Advisory Committee on Immunization Practices
por: Meites, Elissa, et al.
Publicado: (2019)

Cost-effectiveness of Human Papillomavirus Vaccination in the United States
por: Chesson, Harrell W., et al.
Publicado: (2008)

Quadrivalent HPV vaccine safety review and safety monitoring plans for nine-valent HPV vaccine in the United States
por: Gee, Julianne, et al.
Publicado: (2016)

Is vaccine type seropositivity a marker for human papillomavirus vaccination? National Health and Nutrition Examination Survey, 2003–2010()
por: Petrosky, Emiko Y., et al.
Publicado: (2015)

Spotlight on the 9-valent HPV vaccine
por: Lopalco, Pier Luigi
Publicado: (2016)

2463. Post-licensure Surveillance of 9-Valent Human Papillomavirus Vaccine (9vHPV) in the Vaccine Adverse Event Reporting System (VAERS), United States, 2014–2017
por: Arana, Jorge, et al.
Publicado: (2018)

Annual Report to the Nation on the Status of Cancer, 1975–2009, Featuring the Burden and Trends in Human Papillomavirus (HPV)–Associated Cancers and HPV Vaccination Coverage Levels
por: Jemal, Ahmedin, et al.
Publicado: (2013)

Challenges in educating women about human papillomavirus (HPV) and HPV screening test results: Experience from an HPV demonstration project in North-Eastern Thailand
por: Senkomago, Virginia, et al.
Publicado: (2016)

Review of human papillomavirus (HPV) burden and HPV vaccination for gay, bisexual, and other men who have sex with men and transgender women in the United States
por: Meites, Elissa, et al.
Publicado: (2022)

CDC Grand Rounds: Reducing the Burden of HPV-Associated Cancer and Disease
por: Dunne, Eileen F., et al.
Publicado: (2014)

Costs and Cost-Effectiveness of 9-Valent Human Papillomavirus (HPV) Vaccination in Two East African Countries
por: Kiatpongsan, Sorapop, et al.
Publicado: (2014)

Cost-effectiveness analysis of the nine-valent HPV vaccine in Italy
por: Mennini, Francesco Saverio, et al.
Publicado: (2017)

CDC Activities for Improving Implementation of Human Papillomavirus Vaccination, Cervical Cancer Screening, and Surveillance Worldwide
por: Senkomago, Virginia, et al.
Publicado: (2017)

Cost-effectiveness evaluations of the 9-Valent human papillomavirus (HPV) vaccine: Evidence from a systematic review
por: Mahumud, Rashidul Alam, et al.
Publicado: (2020)

962. Trends in Cervical Pre-cancers by Race and Ethnicity During the Human Papillomavirus Vaccine Era, HPV Vaccine Impact Monitoring Project (HPV-IMPACT), United States, 2008–2016
por: Gargano, Julia, et al.
Publicado: (2019)

Impact of the human papillomavirus (HPV) vaccine supply shortage on Tanzania’s national HPV vaccine introduction ()
por: Li, Anyie J., et al.
Publicado: (2022)

Prevalence of high‐risk human papillomavirus after HPV‐vaccination in Denmark
por: Lynge, Elsebeth, et al.
Publicado: (2020)

Human Papillomavirus (HPV) Vaccination Knowledge, Beliefs, and Hesitancy Associated with Stages of Parental Readiness for Adolescent HPV Vaccination: Implications for HPV Vaccination Promotion
por: Jin, Seok Won, et al.
Publicado: (2023)

Correction: Cost-effectiveness evaluations of the 9-Valent human papillomavirus (HPV) vaccine: Evidence from a systematic review
por: Mahumud, Rashidul Alam, et al.
Publicado: (2023)

Human Papillomavirus Vaccination Coverage Among Adolescent Girls, 2007–2012, and Postlicensure Vaccine Safety Monitoring, 2006–2013 — United States
por: Stokley, Shannon, et al.
Publicado: (2013)

Awareness and knowledge of Human Papillomavirus (HPV), HPV‐related cancers, and HPV vaccines in an uninsured adult clinic population
por: Radecki Breitkopf, Carmen, et al.
Publicado: (2016)

Knowledge and Awareness of Cervical Cancer, Human Papillomavirus (HPV), and HPV Vaccine Among HPV-Infected Chinese Women
por: Baloch, Zulqarnain, et al.
Publicado: (2017)

Yellow Fever Vaccine Booster Doses: Recommendations of the Advisory Committee on Immunization Practices, 2015
por: Staples, J. Erin, et al.
Publicado: (2015)

Safety profile of the 9-valent human papillomavirus vaccine: assessment in prior quadrivalent HPV vaccine recipients and in men 16 to 26 years of age
por: Moreira, E. D., et al.
Publicado: (2017)

Immunogenicity of HPV prophylactic vaccines: Serology assays and their use in HPV vaccine evaluation and development
por: Pinto, Ligia A., et al.
Publicado: (2018)

Carcinogenic risk of human papillomavirus (HPV) genotypes and potential effects of HPV vaccines in Korea
por: Park, Eunhyang, et al.
Publicado: (2019)

Human Papillomavirus (HPV) Health Savings as an Alternative Solution: HPV Vaccination Behavior in Adolescents
por: Lismidiati, Wiwin, et al.
Publicado: (2021)

Myths and fake messages about human papillomavirus (HPV) vaccination: answers from the ESGO Prevention Committee
por: Taumberger, Nadja, et al.
Publicado: (2022)

Barriers and Facilitators of Romanian HPV (Human Papillomavirus) Vaccination
por: Manolescu, Loredana Sabina Cornelia, et al.
Publicado: (2022)

Use of Japanese Encephalitis Vaccine in Children: Recommendations of the Advisory Committee on Immunization Practices, 2013
por: Bocchini, Joseph A., et al.
Publicado: (2013)

Monitoring the impact of HPV vaccine in males—Considerations and challenges
por: Brotherton, Julia M.L., et al.
Publicado: (2016)

Substantial Decline in Prevalence of Vaccine-Type and Nonvaccine-Type Human Papillomavirus (HPV) in Vaccinated and Unvaccinated Girls 5 Years After Implementing HPV Vaccine in Norway
por: Feiring, Berit, et al.
Publicado: (2018)

Gaps in detailed knowledge of human papillomavirus (HPV) and the HPV vaccine among medical students in Scotland
por: McCusker, Sarah M, et al.
Publicado: (2013)

Burden of Human papillomavirus (HPV)-related disease and potential impact of HPV vaccines in the Republic of Korea
por: Kim, Young-Tak, et al.
Publicado: (2018)

Knowledge and awareness of Human Papillomavirus (HPV) and HPV vaccines among Caribbean youth: the case of the Bahamas
por: George, Clemon, et al.
Publicado: (2019)

Knowledge of Human Papillomavirus (HPV) and Oropharyngeal Cancer and Acceptability of the HPV Vaccine among Dental Students
por: Farsi, Nada J, et al.
Publicado: (2020)

Human Papillomavirus Vaccination Coverage Among Adolescents, 2007–2013, and Postlicensure Vaccine Safety Monitoring, 2006–2014 — United States
por: Stokley, Shannon, et al.
Publicado: (2014)

Bivalent Human Papillomavirus (HPV) Vaccine Effectiveness Correlates With Phylogenetic Distance From HPV Vaccine Types 16 and 18
por: Bogaards, Johannes A, et al.
Publicado: (2019)

HPV and Cytology Testing in Women Undergoing 9-Valent HPV Opportunistic Vaccination: A Single-Cohort Follow Up Study
por: De Vincenzo, Rosa, et al.
Publicado: (2021)

Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine Among Adults Aged ≥65 Years: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
por: Tomczyk, Sara, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_9vo9tkitcofebhq8n50os4s53i